ReP USP - Resultado da busca

Artigo de periodico-carta/editorial
Comment on [Carta]: “Excipients in neonatal medicinal products: never prescribed, commonly administered” (2020)
Santos, Carlos Eduardo Matos dos; Dorta, Daniel Junqueira ; Oliveira, Danielle Palma de
Source: Pharmaceutical Medicine. Unidades: FFCLRP, FCFRP
Subjects: MEDICAMENTO, RECÉM-NASCIDO, FARMACOLOGIA CLÍNICA, TOXICOLOGIA, AVALIAÇÃO DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Carlos Eduardo Matos dos e DORTA, Daniel Junqueira e OLIVEIRA, Danielle Palma de. Comment on [Carta]: “Excipients in neonatal medicinal products: never prescribed, commonly administered”. Pharmaceutical Medicine. Cham: Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1007/s40290-020-00357-6. Acesso em: 24 abr. 2026. , 2020
APA
Santos, C. E. M. dos, Dorta, D. J., & Oliveira, D. P. de. (2020). Comment on [Carta]: “Excipients in neonatal medicinal products: never prescribed, commonly administered”. Pharmaceutical Medicine. Cham: Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, Universidade de São Paulo. doi:10.1007/s40290-020-00357-6
NLM
Santos CEM dos, Dorta DJ, Oliveira DP de. Comment on [Carta]: “Excipients in neonatal medicinal products: never prescribed, commonly administered” [Internet]. Pharmaceutical Medicine. 2020 ; 34( 5): 359-360.[citado 2026 abr. 24 ] Available from: https://doi.org/10.1007/s40290-020-00357-6
Vancouver
Santos CEM dos, Dorta DJ, Oliveira DP de. Comment on [Carta]: “Excipients in neonatal medicinal products: never prescribed, commonly administered” [Internet]. Pharmaceutical Medicine. 2020 ; 34( 5): 359-360.[citado 2026 abr. 24 ] Available from: https://doi.org/10.1007/s40290-020-00357-6
Artigo de periodico
Using data from the Canadian post-marketing spontaneous pharmacovigilance system for drug safety research: a feasibility study (2020)
Akinola, Pelumi Samuel; Silveira, Carolina Galli da ; Corbin, Sonia; Lavallée, Maude; Thibault, Magalie; Gonella, Jennifer Midiani; Sousa, Fernanda Raphael Escobar Gimenes de ; Leclerc, Jacinthe
Source: Pharmaceutical Medicine. Unidade: EERP
Subjects: ANTAGONISMO DE DROGAS, ANTICOAGULANTES, VIGILÂNCIA DE PRODUTOS COMERCIALIZADOS, FARMACOVIGILÂNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AKINOLA, Pelumi Samuel et al. Using data from the Canadian post-marketing spontaneous pharmacovigilance system for drug safety research: a feasibility study. Pharmaceutical Medicine, v. 34, n. 4, p. 263-269, 2020Tradução . . Disponível em: https://doi.org/10.1007/s40290-020-00345-w. Acesso em: 24 abr. 2026.
APA
Akinola, P. S., Silveira, C. G. da, Corbin, S., Lavallée, M., Thibault, M., Gonella, J. M., et al. (2020). Using data from the Canadian post-marketing spontaneous pharmacovigilance system for drug safety research: a feasibility study. Pharmaceutical Medicine, 34( 4), 263-269. doi:10.1007/s40290-020-00345-w
NLM
Akinola PS, Silveira CG da, Corbin S, Lavallée M, Thibault M, Gonella JM, Sousa FREG de, Leclerc J. Using data from the Canadian post-marketing spontaneous pharmacovigilance system for drug safety research: a feasibility study [Internet]. Pharmaceutical Medicine. 2020 ; 34( 4): 263-269.[citado 2026 abr. 24 ] Available from: https://doi.org/10.1007/s40290-020-00345-w
Vancouver
Akinola PS, Silveira CG da, Corbin S, Lavallée M, Thibault M, Gonella JM, Sousa FREG de, Leclerc J. Using data from the Canadian post-marketing spontaneous pharmacovigilance system for drug safety research: a feasibility study [Internet]. Pharmaceutical Medicine. 2020 ; 34( 4): 263-269.[citado 2026 abr. 24 ] Available from: https://doi.org/10.1007/s40290-020-00345-w
Artigo de periodico
Development of new formulations of biologics: expectations, immunogenicity, and safety for subcutaneous trastuzumab (2018)
Pimentel, Franklin Fernandes; Morgan, Gilberto; Tiezzi, Daniel Guimarães; Andrade, Jurandyr Moreira de
Source: Pharmaceutical Medicine. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS, TERAPIA COMBINADA, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIMENTEL, Franklin Fernandes et al. Development of new formulations of biologics: expectations, immunogenicity, and safety for subcutaneous trastuzumab. Pharmaceutical Medicine, v. 32, n. 5, p. 319-325, 2018Tradução . . Disponível em: https://doi.org/10.1007/s40290-018-0247-5. Acesso em: 24 abr. 2026.
APA
Pimentel, F. F., Morgan, G., Tiezzi, D. G., & Andrade, J. M. de. (2018). Development of new formulations of biologics: expectations, immunogenicity, and safety for subcutaneous trastuzumab. Pharmaceutical Medicine, 32( 5), 319-325. doi:10.1007/s40290-018-0247-5
NLM
Pimentel FF, Morgan G, Tiezzi DG, Andrade JM de. Development of new formulations of biologics: expectations, immunogenicity, and safety for subcutaneous trastuzumab [Internet]. Pharmaceutical Medicine. 2018 ; 32( 5): 319-325.[citado 2026 abr. 24 ] Available from: https://doi.org/10.1007/s40290-018-0247-5
Vancouver
Pimentel FF, Morgan G, Tiezzi DG, Andrade JM de. Development of new formulations of biologics: expectations, immunogenicity, and safety for subcutaneous trastuzumab [Internet]. Pharmaceutical Medicine. 2018 ; 32( 5): 319-325.[citado 2026 abr. 24 ] Available from: https://doi.org/10.1007/s40290-018-0247-5
Artigo de periodico
Factors that motivate healthcare professionals to report adverse drug events: a systematic review (2017)
Abjaude, Samir Antonio Rodrigues; Mieli, Stephania Furlaneto; Magalhães, Zídia Rocha; Pereira, Leonardo Régis Leira
Source: Pharmaceutical Medicine. Unidade: FCFRP
Subjects: MEDICAMENTO, REVISÃO SISTEMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ABJAUDE, Samir Antonio Rodrigues et al. Factors that motivate healthcare professionals to report adverse drug events: a systematic review. Pharmaceutical Medicine, v. 31, n. 1, p. 13-20, 2017Tradução . . Disponível em: https://link.springer.com/article/10.1007/s40290-016-0174-2. Acesso em: 24 abr. 2026.
APA
Abjaude, S. A. R., Mieli, S. F., Magalhães, Z. R., & Pereira, L. R. L. (2017). Factors that motivate healthcare professionals to report adverse drug events: a systematic review. Pharmaceutical Medicine, 31( 1), 13-20. Recuperado de https://link.springer.com/article/10.1007/s40290-016-0174-2
NLM
Abjaude SAR, Mieli SF, Magalhães ZR, Pereira LRL. Factors that motivate healthcare professionals to report adverse drug events: a systematic review [Internet]. Pharmaceutical Medicine. 2017 ; 31( 1): 13-20.[citado 2026 abr. 24 ] Available from: https://link.springer.com/article/10.1007/s40290-016-0174-2
Vancouver
Abjaude SAR, Mieli SF, Magalhães ZR, Pereira LRL. Factors that motivate healthcare professionals to report adverse drug events: a systematic review [Internet]. Pharmaceutical Medicine. 2017 ; 31( 1): 13-20.[citado 2026 abr. 24 ] Available from: https://link.springer.com/article/10.1007/s40290-016-0174-2

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Indexado em